Molecular Therapy Advances
Издатель: Elsevier · ISSN 3117-387X · 90 статей
- Sequence-based artificial intelligence-guided inhibitory peptides to counteract AAV neutralizing antibodies in gene therapy
- Base editing rescues a hereditary motor neuron disease in mouse and patient-derived iPSC organoid models
- Automated zonal-rotor CsCl ultracentrifugation with ÄKTA-based fractionation removes empty and intermediate AAV capsids
- Digenome-Detect: Accurate, statistics-based analysis software for identifying off-target cleavage sites in genome editing
- Transduction efficiency in clinical CAR T cell products: A retrospective study at a single center
- pSIM: A next generation in vitro mRNA potency assay
- Calcineurin-mediated regulation of macrophage plasticity drives anti-tumor activity
- Integrating multiplex digital PCR and long-read sequencing toward standardized genome integrity and purity characterization of rAAV9
- DNA ejection and AAV capsid degradation under thermal stress: Insights from CDMS and native digestion strategies
- Development and qualification of quantitative assays for detecting process-related nucleic acid impurities in recombinant AAV preparations
- Seeing the invisible: How RNA extraction and library prep shape viral read recovery in RNA-seq
- AAV vector-mediated ALDH5A1 gene replacement improves survival and metabolic correction in a severe mouse model of SSADH deficiency
- Functional improvement of dystrophic muscle by utrophin gene editing
- Systemic, RPE-directed AAV-tyrosinase therapy restores ocular pigmentation in an OCA1 mouse model
- Bovine AAV: A promising vector for pulmonary gene therapy
- Transplanted human photoreceptors differentially survive, incorporate, and mature in mildly and severely degenerated mouse retinae
- A dual-switch safety system enables safety controllability and high-efficiency enrichment for T cell immunotherapy
- A novel technology-driven enzyme replacement therapy for Pompe disease
- AAV-mediated genome targeting of the GLA cDNA in newborn and juvenile Gla KO mice achieves long-term correction of Fabry disease
- Long-read genome sequencing reveals complex variability in lentiviral provirus insertions in clonal CD19 CAR-T VCN reference cell lines
- LVV SMRTcap reveals extensive proviral variation in lentiviral vector-transduced CAR T cells
- Optimized GENE TARGET framework characterizes barriers to therapeutic development for monogenic neurodevelopmental disorders
- Development of protein expression and enzymatic activity potency assays for mRNA therapeutic development: A case study using GSDIII mRNA-LNP
- AAV-delivered TNF-α inhibitors for the treatment of non-infectious uveitis
- NIS reporter gene PET imaging reveals expansion kinetics and localization of anti-CD20 CAR-T in mice and nonhuman primates
- VP2-TALE fusions increase AAV2 capsid filling with payload bearing cognate TALE target sequences as determined by qPCR/ELISA
- Subcutaneous administration of adipose-tropic leptin gene therapy for congenital generalized lipodystrophy
- Evaluation of HexM and its high-level mannose 6-phosphorylated form, PhosHexM, as treatments of models of GM2 gangliosidoses
- Single-dose, dual-antigen VSV-based vaccines protect against Crimean-Congo hemorrhagic fever in two lethal mouse models
- AAV-mediated gene therapy as an efficient treatment strategy in fucosidosis mice